Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer's disease
| Autor: | Germaine B. Foka, Erika Kapp, Jacques Joubert, Benjamin P. Repsold, Sarel F. Malan, Douglas W. Oliver |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
0301 basic medicine
Monoamine Oxidase Inhibitors Molecular model Aché Stereochemistry Inhibitory postsynaptic potential Protein Aggregation Pathological 01 natural sciences Structure-Activity Relationship 03 medical and health sciences chemistry.chemical_compound Piperidines Alzheimer Disease Coumarins Benzyl Compounds Drug Discovery Animals Humans Moiety Monoamine Oxidase Cholinesterase Pharmacology Amyloid beta-Peptides Binding Sites Dose-Response Relationship Drug biology Organic Chemistry General Medicine Coumarin Peptide Fragments language.human_language 0104 chemical sciences 010404 medicinal & biomolecular chemistry 030104 developmental biology chemistry language biology.protein Cholinesterase Inhibitors Monoamine oxidase B Piperidine Protein Binding |
| Zdroj: | European Journal of Medicinal Chemistry. 125:853-864 |
| ISSN: | 0223-5234 |
| DOI: | 10.1016/j.ejmech.2016.09.041 |
| Popis: | A series of 7-substituted coumarin derivatives were designed and synthesised to display ChE and MAO-B inhibitory activity. The compounds consisted out of a coumarin structure (MAO-B inhibitor) and benzyl-, piperidine-, N -benzylpiperidine- or p -bromo- N -benzylpiperizine moiety, resembling the N -benzylpiperidine function of donepezil (ChE inhibitor), connected via an alkyl ether linkage at the 7 position. The biological assay results indicated that all the compounds ( 1 – 25 ) displayed selective inhibition to hMAO-B over hMAO-A, with the benzyloxy series ( 1 – 8 , 10 – 13 ) showing nano-molar hMAO-B inhibition (IC 50 : 0.5–73 nM). Limited ChE inhibitory activity was however observed for the benzyloxy series with the exception of 2 and especially 3 showing selective BuChE inhibition. From this series 3 showed the best multifunctional activity (eqBuChE IC 50 = 0.96 μM, hMAO-A IC 50 = 2.13 μM, hMAO-B IC 50 = 0.0021 μM). Within the N -benzylpiperidine ( 16 – 19 ) and p -bromo- N -benzylpiperizine ( 21 – 24 ) series the compounds in general showed moderate ChE and MAO-B inhibitory activity. Of these compounds 19 was the most potent multifunctional agent showing good eeAChE and eqBuChE inhibition (IC 50 = 9.10 μM and 5.90 μM, respectively), and relatively potent and selective hMAO-B inhibition (IC 50 = 0.30 μM, SI = >33). Molecular modeling revealed that 19 was able to bind simultaneously to the CAS, mid-gorge and PAS sites of AChE and BuChE suggesting that it will be able to inhibit AChE induced Aβ aggregation. From this study, compounds that 3 and 19 can be considered as promising multifunctional lead compounds. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect